07:00 , Aug 30, 1999 |  BioCentury  |  Finance

The momentum returns

Momentum investors have vigorously returned to the biotech space, and it's becoming clear that their aggregate buying is responsible for several of the monstrous price gains in the big cap (over $1 billion) names. As...